P2X7-dependent immune pathways in retinal diseases

被引:7
|
作者
Dechelle-Marquet, Paul-Alexandre [1 ]
Guillonneau, Xavier [1 ]
Sennlaub, Florian [1 ]
Delarasse, Cecile [1 ]
机构
[1] Sorbonne Univ, Inst Vis, INSERM, CNRS, 17 Rue Moreau, F-75012 Paris, France
关键词
Retina; Age-related macular degeneration; Uveitis; Macrophage; Microglia; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PURINERGIC P2X7 RECEPTOR; EXTRACELLULAR ATP; NLRP3; INFLAMMASOME; P2X(7); RELEASE; CELLS; MICROGLIA; ACTIVATION; PHAGOCYTES;
D O I
10.1016/j.neuropharm.2022.109332
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Adenosine triphosphate (ATP) is a signalling molecule acting as a neurotransmitter but also as a danger signal. The purinergic receptor P2X7 is the main sensor of high concentration of ATP released by damaged cells. In the eye, P2X7 is expressed by resident microglia and immune cells that infiltrate the retina in disease such as age -related macular degeneration (AMD), a degenerative retinal disease, and uveitis, an inflammatory eye disease. Activation of P2X7 is involved in several physiological and pathological processes: phagocytosis, activation of the inflammasome NLRP3, release of pro-inflammatory mediators and cell death. The aim of this review is to discuss the potential involvement of P2X7 in the development of AMD and uveitis.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Editorial: P2X7 Receptor Function in Neurodegenerative Diseases
    Faria, Robson Xavier
    Melo Reis, Ricardo Augusto
    Gallart-Palau, Xavier
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [32] The P2X7 Receptor: Central Hub of Brain Diseases
    Andrejew, Roberta
    Oliveira-Giacomelli, Agatha
    Ribeiro, Deidiane Elisa
    Glaser, Talita
    Arnaud-Sampaio, Vanessa Fernandes
    Lameu, Claudiana
    Ulrich, Henning
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13
  • [33] The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
    Savio, Luiz E. B.
    Mello, Paola de Andrade
    da Silva, Cleide Goncalves
    Coutinho-Silva, Robson
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [34] P2X7 Receptors as a Therapeutic Target in Cerebrovascular Diseases
    Cisneros-Mejorado, Abraham J.
    Perez-Samartin, Alberto
    Domercq, Maria
    Arellano, Rogelio O.
    Gottlieb, Miroslav
    Koch-Nolte, Friedrich
    Matute, Carlos
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13
  • [35] Targeting P2X7 receptors as a means for treating retinal disease
    Fletcher, Erica L.
    Wang, Anna Y.
    Jobling, Andrew I.
    Rutar, Matthew V.
    Greferath, Ursula
    Gu, Ben
    Vessey, Kirstan A.
    DRUG DISCOVERY TODAY, 2019, 24 (08) : 1598 - 1605
  • [36] CHANGES IN RETINAL P2X7 RECEPTORS IN A MURINE MODEL OF GLAUCOMA
    Pintor, Jesus
    de la Villa, Pedro
    Jesus Perez de Lara, Maria
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [37] HUMAN RETINAL PERICYTES PROTECTION: ROLE OF P2X7 RECEPTOR
    Bucolo, Claudio
    Platania, Chiara B. M.
    Giurdanella, Giovanni
    Drago, Filippo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [38] Modulation of three key innate immune pathways for the most common retinal degenerative diseases
    Akhtar-Schaefer, Isha
    Wang, Luping
    Krohne, Tim U.
    Xu, Heping
    Langmann, Thomas
    EMBO MOLECULAR MEDICINE, 2018, 10 (10)
  • [39] SHEAR STRESS DEPENDENT REGULATION OF P2X4 AND P2X7 RECEPTORS IN THE ENDOTHELIUM
    Green, Jack
    Wilson, Heather
    Evans, Paul
    HEART, 2015, 101 : A104 - A104
  • [40] Antagonistic Roles of P2X7 and P2Y2 Receptors in Neurodegenerative Diseases
    Glaser, Talita
    Oliveira-Giacomelli, Agatha
    Petiz, Lyvia Lintzmaier
    Ribeiro, Deidiane Elisa
    Andrejew, Roberta
    Ulrich, Henning
    FRONTIERS IN PHARMACOLOGY, 2021, 12